Bright spots in tackling AMRs, but drug-resistance outpaces pharma industry efforts: Report
Drug resistance is outpacing industry-wide efforts, says Netherlands-based Access to Medicine Foundation in its latest Antimicrobial Resistance (AMR) Benchmark report, even as it identified seven innovative late-stage projects that targetted certain drug- …